1.
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
by Holmes, David R, Prof
The Lancet (British edition), 2009, Vol.374 (9689), p.534-542

2.
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and mo...
by Ducharme, Anique
The American heart journal, 2006, Vol.152 (1), p.86-92

3.
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study
by Schnabel, Renate B, MD
The Lancet (British edition), 2009, Vol.373 (9665), p.739-745

4.
Atrial fibrillation is associated with different levels of physical activity levels at different ages in men
by Drca, Nikola
Heart (British Cardiac Society), 2014-07, Vol.100 (13), p.1037-1042

5.
Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials
by Martin, Ruairidh I R
Heart (British Cardiac Society), 2014-10, Vol.100 (19), p.1506-1510

6.
Effects of Alpha Lipoic Acid on Multiple Cytokines and Biomarkers and Recurrence of Atrial Fibrillation Within 1 Year of Catheter Ablation
by Sardu, Celestino
The American journal of cardiology, 2017-05-01, Vol.119 (9), p.1382-1386

7.
Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study
by Watanabe, Hiroshi, MD, PhD
The American heart journal, 2009, Vol.158 (4), p.629-636

8.
Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies
by Caldeira, Daniel
Heart, 2013-10, Vol.99 (19), p.1383-1389

9.
Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women
by Drca, Nikola
Heart (British Cardiac Society), 2015-10, Vol.101 (20), p.1627-1630

10.
From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century
by Blacher, Jacques, Prof
The Lancet (British edition), 2016, Vol.388 (10043), p.530-532

11.
Effect of Omega-Three Polyunsaturated Fatty Acids on Inflammation, Oxidative Stress, and Recurrence of Atrial Fibrillation
by Darghosian, Leon, MD
The American journal of cardiology, 2015, Vol.115 (2), p.196-201

12.
Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial
by Chen, Lin Y
American journal of hypertension, 2016-11, Vol.29 (11), p.1276-1282

13.
Incidence of Device-Detected Atrial Fibrillation and Long-term Outcomes in Patients with Hypertrophic Cardiomyopathy
by van Velzen, Hannah G., MD
The American journal of cardiology, 2016, Vol.119 (1), p.100-105

14.
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012
by Hess, Paul L., MD
American heart journal, 2014, Vol.168 (3), p.239-247.e1

15.
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
by Maggioni, Aldo P
The American heart journal, 2005, Vol.149 (3), p.548-557

16.
Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation
by De Vos, C B
Heart (British Cardiac Society), 2009-05, Vol.95 (10), p.835-840

17.
Effect of ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Trial
by Tabbalat, Ramzi A., MD, FACC
The American heart journal, 2015, Vol.178, p.102-107

18.
Comparison of Effectiveness and Safety of Ranolazine Versus Amiodarone for Preventing Atrial Fibrillation After Coronary Artery Bypass Grafting
by Miles, Ronald H., MD
The American journal of cardiology, 2011, Vol.108 (5), p.673-676

19.
Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials
by Liu, Tong
Heart, 2011-07, Vol.97 (13), p.1034-1040

20.
Perioperative supplementation with ascorbic acid does not prevent atrial fibrillation in coronary artery bypass graft patients
by Bjordahl, Paul M., M.D
The American journal of surgery, 2012, Vol.204 (6), p.862-867
